Medical Devices are regulated in China, PDF/PPT

Save (0)




Regulatory Body :
● Medical Devices are regulated in China by the National Medical Products

Administration (NMPA). Formerly known as the China Food and Drug
Administration (CFDA). (Est. in 1998 and renamed in 2018)

● The NMPA departments dealing with medical devices are:

○ Department Of Medical Device Registration – Responsible for Pre-
Market Approval

○ Department of Medical Device Supervision – responsible for post-
market supervision Page 1 Of 23


THE MARKET How To Enter The Chinese Market ?

Faster market Entry and low

8.3% captial investment
Global Share

($ 42 bn approx.) SET UP LOCAL OPERATION
More Capital and Longer time to
enter, but beneficial in the long – run

(Source : https://www.medicaldevice- A local OEM partner helps the company meet local production mandates, thereby reducing regulatory

barriers Page 2 Of 23


Salient Features
o Separate concept of IVD does not exist

in China.

o GB (Guobiao) and YY standards similar
to CE certification in EU.

o Devices from Hong Kong , Macau and
Taiwan are considered imported.

o UDI requirements are similar to those
in the US and European Union Page 3 Of 23


Risk Based Classification
Class I Class II Class III

Low Risk Moderate Risk High Risk

Mostly implanted into
human body used for life

Safety and Effectiveness Strict control is required to
Support. Strict control and

can be ensured by routine ensure the safety
special methods required

administration and effectiveness
to ensure the safety and

Examples: Electrical Examples: Ventilators,
Examples: Canes,

wheelchairs, ECG machine, COVID-19 test kits
Examination gloves, goggles

Blood pressure monitors Orthopaedic implants,

Record filing with NMPA Registration (Provincial level) Registration with NMPA Page 4 Of 23


Classification Based On Body Contact

Medical Device Temporary Short Term Long Term


Medical Dressing I II II I II II – III III

Invasive Instruments I II III II II III – – –

Reusable Surgical I I II – – – – – –

Implanted Devices – – – – – – III III III

S : Skin or Body Orifice , T: Injured Tissue, C : Central Circulatory or Nervous System Page 5 Of 23


Time, Cost and Complexity of Registration
Classification Class I Class II Class III

Time required for approval < 1 Week 12-20 months 12-22 months

Validity of registration Does not expire 5 Years 5 Years

Renewal should be started Not Applicable 18-24 months 18-24 months
this far in advance

Cost $10,000 – $15,000 > $50,000 > $50,000 Page 6 Of 23


02 Approval Process :
● Approval of medical device based on – Classification and Origin.

● The Classification – Class I, Class II and Class III.

● Origin – Domestic and Imported.

● For imported medical device – Applicants needs to designate a representative
office or an agent within the territory of China to conduct the application.

● All documents must be provided in simplified Chinese.

● Before initiating the application to sell an imported device in China the device
must be approved for use by the country of the origin of the device Page 7 Of 23


Flow Chart Of The Approval Process
Medical Products If required

Clinical Trial Application


Clinical Trial

Authorize representative
office or agent in China Filing application (self Registration Application

testing can be submitted)

Classification Correction and Correction and

requirement of requirement of
supplementary documents

supplementary documents

Class I Product technical Class II & Class III Administrative Administrative

requirement preparation evaluation on evaluation on

application materials application materials

Correction and requirement of

Provide testing sample, technical supplementary documents

and other materials for application Technical Evaluation
of registration testing

Filing approved
and fliling-

Registration approved and
Registration testing based on the certificate granted

product technical requirement

granted Page 8 Of 23


Approval Process :
● STEP 1

● Determine classification of medical device in China according to China Food and
Drug Administration (CFDA).

● STEP 2
● Prepare product technical requirement document according to CFDA. The product

technical requirements contains details of testing that needs to be conducted
before registration.

● STEP 3
● Imported class II and III devices, needs to undergo type testing where the foreign

medical device must be sent to accredited testing institutes by NMPA in China. The
testing must be conducted by a qualified testing institute of medical devices,
following the product technical requirement.

● The test center must be approved by the State Food Drug Supervision
Administration and the State Quality Supervision Inspection and Quarantine
Administration. Page 9 Of 23


Approval Process : Page 10 Of 23


Approval Process :
● STEP 4

● For Classes II and III devices, clinical trials conducted in China might be required.
● According to the guidelines for clinical trials recently published by CFDA, imported

medical devices that fulfill the following requirements no longer need an extra
clinical trial in China:

1. The imported medical device is already tested in clinical trial outside the territory of

2. The conducted clinical trial outside the territory of China fulfills the technical
requirements of Chinese regulations and technical guidance for registration, such as
sample size, control group selection, evaluation indexes and evaluation principles,
etc. Page 11 Of 23


Approval Process :
● STEP 5

● Submit dossier for application of filing (class I devices) or registration (class II and III

● Applicants of class I devices can submit a self-testing report.
● For imported class I devices, the results of tests conducted outside the territory of

China are usually acceptable.
● For class II and III devices, test results both in the home country and in China are

● Applicants of imported devices need to submit a notarized agent authorization

letter, test reports, clinical trial data (if required), proof of home country approval,
e.g., Certificate of Free Sale (CFS) or Certificate to Foreign Government (CFG),
notarized proof of qualification of the manufacturer, e.g., CE-Certificate or
Premarket Approval (PMA) following ISO-13485 or 510(k) letter, and other
documents. Page 12 Of 23


Approval Process :
● STEP 6

● For Class I devices, an administrative review is conducted, while the submitted
application documents of class II and III devices undergo an administrative review
and a technical review.

● In some cases, QMS inspection will be organized by the regulatory authority. A
technical review with external experts or a joint review with drug review institutes
is sometimes required, which takes extra time.

● STEP 7
● Class I devices which successfully pass the review of regulatory authority receive a

Filing-Certificate, which does not expire. For Class II and III devices, the regulatory
authority issues Registration-Certificates following successful review.

● A Registration-Certificate is valid for 5 years. Page 13 Of 23


1. Application Form
2. Legal documentation

• Registration certificate, proof of qualification of the manufacturer which are issued by an
accredited authority in the original country of registration and production.

• QMS Certificate
• Authority, obligation and copies of business license or registration certificate of the

designated agencies.
3. Checklist for medical device safety and effectiveness requirements
4. Summarized documentation

• Overview
• Product description
• Model specification
• Packaging description
• Scopes and contraindications
• Overview previous generations or similar products (if exist)
• Other Page 14 Of 23


● 5. Research documentation

• Performance study
• Evaluation of biocompatibility
• Research data of biosecurity
• Validation data of sterilization and disinfection technology
• Research data of the validity and packaging
• Animal research data
• Software validation data

● 6. Production documentation
• Description of the manufacturing processes for active / passive products
• Production site

● 7. Clinical evaluation documentation
● 8. Risk analysis documentation
● 9. Product technical requirements Page 15 Of 23


● 10. Type-test report

• Review of the CFDA
• Comments on the Pre-Evaluation

● 11. Design of operation manual and label
• Operation manual
• Label for the smallest sales unit

● 12. Declaration of conformity
• Declaration of conformity with „The Regulations for the Supervision and Administration of

Medical Devices“ and other related regulations
• Declaration of the authenticity of documents submitted Page 16 Of 23



DEATH Must Be reported within 5 Days

INJURY Reported within 15 days after discovery

Annual Report Manufacturers must submit Summary of
adverse events for class II and Class III devices.

If severe injuries or a death was caused an expert

RECALL team reevaluates the device in order to decide
whether to demand a recall or revoke the registration
certificate. A failure to recall results in fines
three times the value of the device. Page 17 Of 23



● China’s new Regulation on the Supervising and Administration of Medical Device
(the “New Regulation”) took effect on 1 June 2021. The New Regulations are a
third revision of the regulations which were first promulgated in April of 2000.

● The most important changes under the New Regulation focus on the reform of the
current medical device application, review and approval process, encouraging
innovation in the industry as well as formalizing the mechanism taking research
and development to commercialisation. Page 18 Of 23


● Expansion of MAH System Nationwide

o The Revised RSAMD stipulates that a medical device MAH is ultimately responsible
for the safety, quality, and efficacy of the device throughout its whole life cycle
and sets forth a concrete, consolidated list of MAH responsibilities and obligations,
including research and development, manufacturing, distribution, and
post-marketing surveillance.

o The MAH remains ultimately responsible for the quality management of the entire
manufacturing process, and should ensure that the production is carried out in
accordance with legal and regulatory requirements of China.

o If distribute their own registered or filed devices, MAHs are exempt from
obtaining a medical device distribution license. Page 19 Of 23


● Encouragement Of Innovation

i. Article 8 permits priority review and approval of innovative medical devices.
Article 9 calls for support for the promotion and application of new medical
devices technologies. Article 26 encourages medical institutions to undertake
clinical trials of innovative medical devices.

ii. Priority Review
iii. Conditional Approval
iv. Emergency Use
v. One-time Importation of Medical Devices for Urgent Clinical Need :- NMPA has

authorized Hainan PMPA to approve this kind of one-time importation in the
Hainan Bo’ao Medical Tourism Pilot Zone since 2018, and the Revised RSAMD
expands this authority nationwide.

vi. Laboratory Developed Tests
vii. Prohibition on the Import of Used Medical Devices Page 20 Of 23


● Facilitating Medical Device Registration and Filing

i. Self inspection :- alleviate the problem of limited capacity amongst certified
third-party medical device inspection institutions and the rapidly growing demand
for inspection within the industry

i. The Revised RSAMD also exempts innovative medical devices that have not yet
been marketed overseas from submitting the marketing authorization in foreign
jurisdictions when applying for registration in China. This means that imported
medical devices do not have to wait for marketing authorization abroad to register
in China

❑ Clinical Evaluation Reform
i. Clinical Trial Implicit Approval ii. Clinical Evaluation Exemption

iii. Expanded Access Programs Page 21 Of 23


● Medical Device Distribution

i. New Exemption for Medical Device Distribution Filing.
ii. Exemption for imported innovative medical devices
iii. Medical Device Online Distribution
iv. Penalty Exemption for Certain Distributors

❑ Improvement of the Medical Device Traceability System

MAHs are required to establish a product tracing system, and medical device
distributors and users, such as hospitals, are required to retain appropriate records and
implement the medical device traceability system( UDI)

❑ Enhanced Penalties
Liability for Violation of Medical Device GCPs Page 22 Of 23


• China has developed its own regulation independently of the GHTF.

• The definitions is almost similar excludes IVDs and classification is on risk basis

• China compulsory certifications is there for certain medical devices

• Independent laboratories for inspection :- QMS, manufacturing site.

• Review by municipal authority

• Labelling for medical device :- Chinese language

• Keep on updating and in regulatory section has various news ,notices, inspection
reports, examination results, amended regulations, specification has been given. Page 23 Of 23





– China Product Registration, Renewal & Modification – China Med


in-china/ Made In China